A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents

Molecular Pharmacology

Volumn 54, Issue 1, 1998, Pages 220-230

  Salata, Joseph J ^a   Jurkiewicz, Nancy K ^a   Wang, Jixin ^a   Evans, Ben E ^a   Orme, Heidi T ^b   Sanguinetti, Michael C ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIHYDRO 5 (2 FLUOROPHENYL) 3 (1H INDOL 3 YLMETHYL) 1 METHYL 2H 1,4 BENZODIAZEPIN 2 ONE; BENZODIAZEPINE DERIVATIVE; ISOPRENALINE; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; GUINEA PIG; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; STEREOSPECIFICITY; XENOPUS LAEVIS;

EID: 0031845332     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.1.220     Document Type: Article

References (31)

1. Ks cardiac potassium current. Nature (Lond) 384:78-80.
2. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 73:379-385.
3. Boyett MR, Coray A, and McGuigan JAS (1980) Cow ventricular muscle. I. The effect of the extracellular potassium concentration on the current-voltage relationship. Pflueg Arch Eur J Physiol 389:37-44.
4. Brown AM, Kunze DL, and Yatani A (1986) Dual effects of dihydropyridines on whole cell and unitary calcium currents in single ventricular cells of guinea pig. J Physiol (Lond) 379:495-514.
5. Ks in guinea pig cardiac myocytes and guinea pig IsK channels by the chromanol 293B. Pflueg Arch Eur J Physiol 432:1094-1096.
6. Carmeliet E and Vereecke J (1969) Adrenaline and the plateau phase of the cardiac action potential. Pflueg Arch Eur J Physiol 313:300-315.
7. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, and Keating MT (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80:795-804.
8. Delcarpio JB, Lanson NA Jr, Field LJ, and Claycomb WC (1991) Morphological characterization of cardiomyocytes isolated from a transplantable cardiac tumor derived from transgenic mouse atria (AT-1 cells). Circ Res 69:1591-1600.
9. Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Gould NP, Lundell GF, Homnick CF, Veber DF, Anderson PS, Chang RSL, Lotti VJ, Cerino DJ, Chen TB, Kling PJ, Kunkel KA, Springer JP, and Hirshfield J (1987) Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists. J Med Chem 30:1229-1239.
10. Fermini B, Jurkiewicz NK, Jow B, Guinosso PJ Jr, Baskin EP, Lynch JJ Jr, and Salata JJ (1995) Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents. J Cardiovasc Pharmacol 26:259-271.
11. Field LJ (1988) Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science (Washington D C) 239:1029-1033.
12. Giles WR and Shibata EF (1985) Voltage clamp of bull-frog cardiac pace-maker cells: a quantitative analysis of potassium currents. J Physiol (Lond) 368:265-292.
13. 3+ block of the currents expressed in Xenopus oocytes. Pflueg Arch Eur J Physiol 426:139-145.
14. Kr. Circulation 94:2938-2946.
15. Kass RS and Wiegers SE (1982) The ionic basis of concentration-related effects of noradrenaline on the action potential of calf cardiac Purkinje fibres. J Physiol (Lond) 322:541-558.
16. Kokubun S, Prod'hom B, Porzig H, and Reuter H (1986) Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers. Mol Pharmacol 30:571-584.
17. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Fauré S, Gary F, Coumel P, Petit C, Schwartz K, and Guicheney P (1997) A novel mutation in the potassium channel gene KvLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 15:186-189.
18. Ks in guinea pig ventricular myocytes. Circulation 94:I-529.
19. 1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 76:110-119.
20. Ks that acts via a negative shift in the voltage dependence of activation. Biophys J 72:A142.
21. + channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci USA 93:2208-2212.
22. Ks potassium channel. Nature (Lond) 384:80-83.
23. Kr potassium channel. Cell 81:299-307.
24. + current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195-215.
25. Sanguinetti MC, Jurkiewicz NK, Scott A, and Siegl PKS (1991) Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes: mechanism of action. Circ Res 68:77-84.
26. Sanguinetti MC and Salata JJ (1996) Cardiac potassium channel modulators: potential for antiarrhythmic therapy, in Potassium Channels and their Modulaters (Evans JM, Hamilton TC, Longman SD, Stemp G, eds) Taylor and Francis, London.
27. Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, Kass D, Feldman AM, and Marban E (1994) Sudden cardiac death in heart failure: the role of abnormal repolarization. Circulation 90:2534-2539.
28. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, and Keating MT (1996) Positional cloning of a novel potassium channel gene: KvLQT1 mutations cause cardiac arrhythmias. Nat Genet 12:17-23.
29. ++ channels in guinea pig atrial cells. J Pharmacol Exp Ther 268:1135-1142.
30. Kr: implications for torsade de pointes and reverse use-dependence. Circulation 93:407-411.
31. + channel mRNA in cultured atrial cardiac myocytes (AT-1 cells). Circ Res 75:870-878.